Notes / Company

Anupam Rasayan India Ltd.

ANURAS BSE 543275 ISIN INE930P01018 Chemicals

Fundamentals

Market cap: ₹14,517 cr
P/E: 85.33×
ROE: 3.28%
Debt / equity: 0.46
Div yield: 0.12%
52-week range: 1045.20 — 1415.00

Research on Tijori Finance

Company snapshot

Anupam Rasayan India Ltd.

Chemicals

₹14,509 cr

P/E 85.29×

Latest quarter · Mar 2026

Sales₹636 cr

Net profit₹56 cr

Op. margin+21.6%

EPS₹3.75

Strength & growth

Debt / equity0.46×

Current ratio1.42×

The timeline — 2 notes on Anupam Rasayan India Ltd.

June 2026

11 Jun 26 · 7:59 PM IST Brief

Brief · Mid cap

Anupam Rasayan scores a global first in ETFA production

The company claims a world-first commercialisation of Ethyl trifluoroacetate via continuous flow chemistry, with an addressable market of **$500–600M** but no revenue number yet.

May 2026

25 May 26 · 6:48 PM IST Brief

Brief · Concalls · Mid cap

Anupam Rasayan cuts EBITDA margin guidance by 200 bps, flags consolidation drag

Management now expects an EBITDA margin of 23-24% for FY26, down from 25%, citing the Bliss GVS Pharma consolidation and phasing effects. The ₹14,000 crore order book underpins a 20-30% annual growth outlook.

Verify on exchange BSE filings for ANURAS NSE filings for ANURAS Tijori Finance company page